Company facts
- Headquarters
- Needham, Massachusetts
- Most recent report
- 8-K, filed Sep 10, 2026
- Incorporated
- Delaware
- Filings on record
- 413 filings
- On EDGAR
- CIK 1841387
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 23
News 8 of 85
- 8-K Leadership change Sep 10, 2026
- 8-K Current report on a material event Sep 9, 2026
- 8-K Quarterly results Aug 13, 2026
- 8-K Shareholder vote results Jun 24, 2026
- 8-K Leadership change Jun 16, 2026
- 8-K Current report on a material event May 15, 2026
- 8-K Quarterly results May 14, 2026
- 8-K Quarterly results Mar 12, 2026
Prospectuses and Registrations 8 of 20
- S-8 Registration statement for an employee plan Mar 12, 2026
- 424B5 Prospectus supplement for an offering Feb 20, 2026
- 424B5 Prospectus supplement for an offering Feb 19, 2026
- S-3 Shelf registration statement Aug 14, 2025
- 424B5 Prospectus supplement for an offering Jun 24, 2025
- S-8 Registration statement for an employee plan Mar 13, 2025
- 424B5 Prospectus supplement for an offering Dec 13, 2024
- 424B5 Prospectus supplement for an offering Dec 12, 2024
Proxies 8
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote May 30, 2024
- DEF 14A Proxy statement for a shareholder vote May 23, 2023
- DEFA14A Extra proxy material Sep 2, 2022
- DEF 14A Proxy statement for a shareholder vote Sep 2, 2022
Ownership 8 of 250
- 4 Insider reported a trade Sep 11, 2026
- 144 Notice of a proposed sale of restricted stock Sep 10, 2026
- 4 Insider reported a trade Sep 10, 2026
- 3 Insider reported their initial holding Sep 10, 2026
- 4 Insider reported a trade Aug 19, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 27, 2026
- 4 Insider reported a trade Jul 8, 2026
Other 8 of 27
- ARS Annual report sent to shareholders Apr 29, 2026
- EFFECT Notice that a registration became effective Aug 22, 2025
- CORRESP Reply to SEC staff Aug 20, 2025
- UPLOAD Comment letter from SEC staff Aug 20, 2025
- ARS Annual report sent to shareholders Apr 29, 2025
- ARS Annual report sent to shareholders May 30, 2024
- ARS Annual report sent to shareholders May 23, 2023
- EFFECT Notice that a registration became effective Aug 12, 2022
Everything here comes from Candel Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.